Director, President and CEO · MADRIGAL PHARMACEUTICALS, INC. · Common Stock
Side
SELL
Value
$57K
Shares
106
Price
$534.06
Executed
Sep 11, 2026
Disclosed
Sep 11, 2026
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Sep 11 executedSep 11, 2026 disclosed
MDGL · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 0 business days after execution (deadline: 2)
Historical behavior+1 / 15
Routine: 16 prior trades recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Sibold William John filed this Form 4 reporting a open-market sale of MDGL on Sep 11, 2026. It became public on Sep 11, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, President and CEO
Sibold William Johncik:0001518611
Issuer
MADRIGAL PHARMACEUTICALS, INC.cik:0001157601
Revision history · 0
No field has changed since this record was first ingested.
